PEGASUS - Improving Treatment for Patients with Emotionally Unstable Personality Disorder
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
100 participants
Sep 1, 2024
INTERVENTIONAL
Conditions
Summary
The purpose of the PEGASUS study is to conduct a pilot trial to test the feasibility and acceptability of the PEGASUS intervention, adding a case manager and family-based interventions meetings to the existing psychiatric integrated care-models known as "Treatment Packages" in Denmark. We will conduct a randomized, assessor-blinded parallel-groups superiority clinical trial, testing the PEGASUS intervention for emotionally unstable personality disorder "EUPD", borderline type (borderline personality disorder) compared to "Treatment as Usual" before moving on to testing in a full-scale trial. Participants will be assessed at baseline and 9 month post baseline at study conclusion
Eligibility
Inclusion Criteria9
- Participating Patients
- Must be able to give an informed written consent.
- Must be newly accepted in the pre-planned BPD treatment packages.
- ≥18 years of age.
- Agreeing to involvement of one or two informal caregivers, families, or close friends ("Relatives").
- Capable of reading and understanding Danish.
- Must be able to give an informed written consent.
- ≥18 years of age.
- Capable of reading and understanding Danish.
Exclusion Criteria3
- None\*
- Note that to get accepted into a treatment package for BPD, patients must not fulfill the criteria for a F20 diagnosis or the criteria for alcohol or substance abuse or harmful use.
- Participating Relatives:
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
See arm description.
See arm description
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06563466